-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna Says Health Canada Authorizes mFLUSIVA And mCOFLU For Adults 50 Years Of Age And Older

Benzinga·11/05/2026 22:26:39
Listen to the news

Canada becomes the first country to authorize both Moderna's mRNA seasonal influenza vaccine, mFLUSIVA®, and combination influenza and COVID-19 vaccine, mCOFLU®

CAMBRIDGE, MA / ACCESS Newswire / November 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that Health Canada has authorized mFLUSIVA® (Influenza mRNA vaccine; mRNA-1010) and mCOFLU® (Combined Influenza and COVID-19 mRNA vaccine; mRNA-1083) for adults 50 years of age and older. Canada is the first country in the world to authorize both Moderna's seasonal mRNA influenza vaccine and combination influenza and COVID-19 vaccine.